Cyndi W. P. v. Frank J. Bisignano, Commissioner of Social Security

• Court: District Court, C.D. California
• Decided: October 21, 2025
• Docket: 5:24-cv-02720
• Status: Unknown

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 CENTRAL DISTRICT OF CALIFORNIA 10 EASTERN DIVISION

12 CYNDI W. P., No. 5:24-cv-02720-BFM

13 Plaintiff, MEMORANDUM OPINION 14 v. A ND ORDER

15 FRANK J. BISIGNANO,1 Commissioner of Social Security, 16 Defendant. 17

18 I. PROCEDURAL HISTORY 19 On April 20, 2022, Plaintiff Cyndi W. P.2 applied for Disability Insurance 20 Benefits, alleging a disability beginning March 1, 2019. (Administrative Record 21 (“AR”) 208-09.) Plaintiff’s application was denied at the initial level of review 22 and on reconsideration, after which she requested a hearing before an 23 Administrative Law Judge (“ALJ”). (AR 71-101, 122.) On October 26, 2023, the 24

25 1 Frank J. Bisignano became the Commissioner of Social Security on May 6, 26 2025. Pursuant to Rule 25(d) of the Federal Rules of Civil Procedure, he is hereby substituted for Carolyn Colvin as the defendant in this suit. 27 2 In the interest of privacy, this Report and Recommendation uses only the 28 first name and last initials of the non-governmental party in this case. 1 ALJ held a hearing and heard from Plaintiff and a vocational expert. (AR 37- 2 70.) After considering the evidence, the ALJ issued an unfavorable decision. (AR 3 21-31.) 4 The ALJ found at step two of the disability analysis3 that Plaintiff suffered 5 from severe lumbar spine degenerative disc disease, asthma, and hearing loss. 6 (AR 23.) The ALJ found that several other medically determinable conditions, 7 including Plaintiff’s carpal tunnel syndrome, were not severe. (AR 24.) The ALJ 8 found Plaintiff retained a residual functional capacity (“RFC”)4 for light work 9 with certain limitations: (1) occasional climbing of ramps and stairs, balancing, 10 stooping, kneeling, and crouching; (2) no climbing of ladders, ropes, or scaffolds, 11 and no crawling; (3) no work at unprotected heights or around dangerous 12 moving machinery; (4) no commercial driving work; (5) occasional exposure to 13 dust, odors, fumes, pulmonary irritants, extreme cold and vibration; and (6) an 14 environment with no more than moderate noise. (AR 26-29 (finding “generally 15 persuasive” the only medical opinions in the record, those of the state agency 16 physicians on initial and reconsideration review, and rejecting Plaintiff’s 17 subjective statements suggesting greater limitations).) At step four, the ALJ 18 found Plaintiff would be capable of performing her past relevant work as an 19 accounting clerk, appointment clerk, and security guard as those jobs are 20 actually and generally performed. (AR 30-31 (adopting vocational expert 21 testimony at AR 62-69).) The ALJ thus concluded that Plaintiff was not disabled 22 from the March 1, 2019, alleged onset date through the November 28, 2023, 23 decision date. (AR 31.) 24

25 3 A five-step evaluation process governs whether a claimant is disabled. 20 26 C.F.R. § 404.1520(a)-(g)(1). Only the steps relevant to the issues raised are discussed herein. 27 4 An RFC is what a claimant can still do despite existing exertional and 28 nonexertional limitations. See 20 C.F.R. § 404.1545(a)(1). 1 The Appeals Council denied Plaintiff’s request for review of the ALJ’s 2 decision. (AR 7-9.) Dissatisfied with the Agency’s resolution of her claim, 3 Plaintiff filed a Complaint in this Court. 4 II. STANDARD OF REVIEW 5 Under 42 U.S.C. § 405(g), the Court reviews the Commissioner’s decision 6 to deny benefits to determine if: (1) the Commissioner’s findings are supported 7 by substantial evidence; and (2) the Commissioner used correct legal standards. 8 See Carmickle v. Comm'r Soc. Sec. Admin., 533 F.3d 1155, 1159 (9th Cir. 2008); 9 Brewes v. Comm'r Soc. Sec. Admin., 682 F.3d 1157, 1161 (9th Cir. 2012). 10 “Substantial evidence. . . is ‘more than a mere scintilla.’ It means—and only 11 means—'such relevant evidence as a reasonable mind might accept as adequate 12 to support a conclusion.’” Biestek v. Berryhill, 587 U.S. 97, 103 (2019) (citations 13 omitted); Gutierrez v. Comm’r of Soc. Sec., 740 F.3d 519, 522-23 (9th Cir. 2014). 14 To determine whether substantial evidence supports a finding, the reviewing 15 court “must review the administrative record as a whole, weighing both the 16 evidence that supports and the evidence that detracts from the Commissioner’s 17 conclusion.” Reddick v. Chater, 157 F.3d 715, 710 (9th Cir. 1998). “If the 18 evidence can reasonably support either affirming or reversing,” the court “may 19 not substitute its judgment” for that of the Commissioner. Id. at 720-21. 20 III. DISCUSSION 21 Plaintiff raises two issues in this Court: (1) that substantial evidence does 22 not support the ALJ’s RFC assessment because the ALJ failed to properly 23 consider her carpal tunnel syndrome and asthma; and (2) that the ALJ 24 impermissibly rejected Plaintiff’s testimony suggesting greater limitations from 25 her asthma than the ALJ found to exist. (ECF 11 at 5-12.) 26 For the reasons set forth below, the Court determines that the ALJ’s 27 decision should be reversed and this matter remanded because the ALJ erred in 28 1 his consideration of Plaintiff’s testimony concerning her asthma-related 2 limitations. The Court therefore need not reach Plaintiff’s other challenges. 3 A. The ALJ Materially Erred in Considering Plaintiff’s Asthma- 4 Related Symptom Testimony 5 Plaintiff argues that the ALJ erred because he (1) did not include in 6 Plaintiff’s RFC assessment certain limitations that flowed from Plaintiff’s 7 asthma—in particular, her need for additional unscheduled breaks to 8 accommodate Plaintiff’s one-hour nebulizer treatments four or more times a 9 day; and (2) did not provide a clear and convincing reasons, supported by 10 substantial evidence, for discounting her testimony that she would require such 11 breaks. (ECF 11 at 8-12.) Both these arguments turn on whether the ALJ 12 properly rejected Plaintiff’s subjective symptom testimony concerning her 13 treatments. 14 1. Legal Framework 15 Where a claimant testifies about subjective medical symptoms, an ALJ 16 must evaluate such testimony in two steps. First, the ALJ must determine 17 whether the claimant has presented objective medical evidence of an underlying 18 impairment that could “reasonably be expected to produce the pain or other 19 symptoms alleged.” Lingenfelter v. Astrue, 504 F.3d 1028, 1036 (9th Cir. 2007) 20 (citation and quotation marks omitted). 21 Second, if the claimant meets that first standard and there is no evidence 22 of malingering, the ALJ can reject the claimant’s testimony only by offering 23 “specific, clear and convincing reasons for doing so.” Id. (citation and internal 24 quotation marks omitted). An ALJ “is not required to believe every allegation of 25 disabling pain, or else disability benefits would be available for the asking, a 26 result plainly contrary to the Social Security Act.” Smartt v. Kijakazi, 53 F.4th 27 489, 499 (9th Cir. 2022) (citation and internal quotation marks omitted). At the 28 same time, when an ALJ rejects a claimant’s testimony, he must “specify which 1 testimony she finds not credible, and then provide clear and convincing reasons, 2 supported by evidence in the record,” to support that determination. Brown- 3 Hunter v. Colvin, 806 F.3d 487, 488-89 (9th Cir. 2015). General or implicit 4 findings of credibility will not suffice; the ALJ must show his work. Smartt, 53 5 F.4th at 499; see also Treichler v. Comm'r of Soc. Sec. Admin., 775 F.3d 1090, 6 1102 (9th Cir. 2014). 7 Judged by that standard, the ALJ’s reasons and explanation for 8 discounting Plaintiff's testimony about her asthma-related symptoms were not 9 sufficient. 10 2. Plaintiff’s Testimony 11 Plaintiff testified about several of her impairments (AR 58-61),5 but 12 challenges only the ALJ’s consideration of her testimony relating to her asthma. 13 (ECF 11 at 9-12.) On that point, she testified that she would not be a reliable 14 employee because she would have to take extra breaks during a workday for 15 breathing treatments. (AR 57-58, 61.) 16 Plaintiff described a typical day: she wakes, takes half a pain pill and rests 17 until she is less stiff and can get out of bed. (AR 54.) Once out of bed, she 18 prepares her first nebulizer breathing treatment, which takes about an hour. 19 (AR 54-56.) After that first treatment, Plaintiff goes for a walk so she can clear 20 her lungs, sits in her hot tub for about an hour to address soreness, eats, and 21 then does another breathing treatment which takes 30 to 40 minutes. (AR 55.) 22 After that second treatment, she goes over her schedule with her 23

24 5 Specifically, Plaintiff testified she is in bed five days a month from pain, 25 cannot sit or stand for more than 15 minutes, must constantly change positions, must take pain medication which makes her drowsy and prevents her from 26 driving and from being alert and oriented, must elevate her legs above her heart for six to eight hours a day due to swelling, and always uses a cane and uses a 27 walker once a month. (AR 58-59.) None of these comments appear related to Plaintiff’s asthma, which is the focus of her claim in his Court. 28 1 caregiver, elevates her legs for swelling from venous insufficiency, and then does 2 another breathing treatment at lunch, which takes an hour. (AR 55.) Plaintiff 3 spends the next hour clearing her lungs, she will lie down and read or crochet, 4 then take a pain pill and nap. (AR 55.) At the end of the day, she takes a pain 5 pill and does another breathing treatment before she goes to bed. (AR 54-56.) 6 Plaintiff testified that she regularly does four breathing treatments a day, 7 but will do “a lot” more when the weather changes. (AR 56.) She said she is 8 prescribed enough medication to do four treatments of one of her solutions, and 9 three treatments of another, or up to seven breathing treatments a day if she 10 needs them. (AR 56.) She had been using a nebulizer for more than 20 years. 11 (AR 56-57.) In terms of activity, she could fold laundry when her caregiver 12 brings it to her, and can make her bed, but she did not use a vacuum or bend or 13 stoop because she loses her balance and falls. (AR 57.) 14 3. The ALJ’s Decision 15 The ALJ summarized Plaintiff’s testimony and agreed that Plaintiff’s 16 impairments “could reasonably be expected to cause the alleged symptoms.” (AR 17 26.) The ALJ concluded, however, that Plaintiff’s statements concerning the 18 intensity, persistence, and limiting effects of these symptoms is “not entirely 19 consistent with the medical evidence and other evidence in the record.” (Id.) 20 The ALJ discussed at length his reasons for discounting Plaintiff’s 21 testimony concerning her back issues, but Plaintiff does not challenge the 22 validity of those reasons. (AR 27-28.) Regarding Plaintiff’s asthma, the ALJ 23 acknowledged that Plaintiff reported flare-ups on numerous occasions and had 24 “characteristic symptoms” including wheezing and dyspnea with exertion. (AR 25 28 (citing AR 370, 376, 401, 466, 493, 2330).) He acknowledged her testimony 26 that flare-ups occur once a month. (See AR 28 (citing AR 370 (March 2022 note 27 reporting exacerbation of symptoms once a month for the past three months); 28 AR 376 (earlier March 2022 note not mentioning frequency of flare-ups).) He 1 noted her prescriptions for inhalers and nebulizers, along with her reported 2 increased need for breathing treatments during flare-ups. (AR 28 (citing AR 3 1784).) He also noted that she sometimes required antibiotics and Prednisone. 4 (AR 28 (citing AR 401-02, 466, 493).) 5 Ultimately, however, the ALJ did not fully credit Plaintiff’s testimony 6 about the severity of her condition. He found that, while Plaintiff testified that 7 she requires four to seven one-hour breathing treatments per day, as well as 8 inhalers between treatments, she never reported such “frequency” of treatment 9 in the treatment notes—even during flare-ups and acute respiratory infections. 10 (AR 28 (citing AR 376, 401, 466, 493, 1332, 1784, 2277, 2330).) Her most recent 11 treatment note reflected that her asthma was “moderate persistent, controlled,” 12 she had no emergency room visits or hospitalizations for her asthma, and she 13 generally had normal pulmonary examinations, even during flare-ups. (AR 28 14 (citing AR 2555).) Finally, a December 2022 report reflected that she was 15 “relatively active” and able to do her activities of daily living in December 2022. 16 (AR 28 (citing AR 386, 405, 1610, 1614, 2281, 2399, 2555, 2638).) 17 4. Analysis 18 The ALJ gave three reasons for discounting Plaintiff testimony about her 19 nebulizer use: (1) the lack of corroboration of the frequency of use of breathing 20 treatments in the medical records; (2) evidence that her condition was 21 “controlled”; and (3) evidence of her level of activity. None of these reasons 22 withstands scrutiny. 23 First, the ALJ found that while Plaintiff said she required four to seven 24 one-hour breathing treatments per day, plus inhalers, she “never reported such 25 frequency of treatment in the treatment notes.” (AR 28.) An ALJ may rely, at 26 least in part, on a lack of supporting objective medical evidence in rejecting 27 Plaintiff’s subjective testimony and statements. See Burch v. Barnhart, 400 28 F.3d 676, 681 (9th Cir. 2005) (“Although lack of medical evidence cannot form 1 the sole basis for discounting pain testimony, it is a factor the ALJ can consider 2 in his [or her] credibility analysis.”); Rollins v. Massanari, 261 F.3d 853, 857 3 (9th Cir. 2001) (same). 4 Contrary to the ALJ’s suggestion, however, there is plentiful evidence 5 supporting Plaintiff’s testimony. Throughout the alleged disability period, 6 Plaintiff was noted to be using her nebulizer solutions “as prescribed”—and 7 “as prescribed” was up to four times a day for Albuterol and Mucomyst, as 8 needed, and up to four times a day for Atrovent, as needed. (AR 370, 376, 381, 9 386, 401-03, 415, 420, 423, 426, 444, 460-61, 467, 520, 533, 535, 537, 541, 562, 10 572, 573, 1564, 1577, 1606, 1614, 1709, 1711, 1800, 1821, 1824, 1828, 2252, 11 2280, 2292, 2297, 2300, 2398, 2501, 3158-59, 3179-80 (treatment notes from 12 August 2019 through July 2023 noting “Outpatient Medications Marked as 13 Taking” as of these visits).) 14 In addition, the record reflects instances of Plaintiff reporting use of her 15 nebulizer four times a day or more. In January 2021, Plaintiff reported she was 16 using Albuterol and Mucomyst three to four times a day for her daily coughing 17 from bronchiectasis, but she was having more mucus production. (AR 459-60.) 18 Her doctor told her to also use Atrovent every six hours as needed. (AR 461.) 19 Plaintiff reported in March 2023, the latest follow-up visit for her 20 bronchiectasis, that she then was using her nebulizer three times a day and was 21 having more mucus production. (AR 2487.) Her pulmonologist told her to use 22 Mucomyst four times a day, and to use Albuterol and Atrovent as needed. (AR 23 2487-88.) These directions were given to address Plaintiff’s bronchiectasis 24 symptoms, which the ALJ (and the state agency physicians) did not distinguish 25 from Plaintiff’s asthma. (AR 28, 75-82, 92-97.) Whether Plaintiff reported using 26 her nebulizer as frequently as she claims, her doctors prescribed and told her to 27 use the nebulizer four or more times a day. Plaintiff’s asserted failure to report 28 1 the frequency of her treatment at the levels she claimed is not a clear and 2 convincing reason for discounting Plaintiff’s testimony.6 3 The ALJ next cited facts reflecting that Plaintiff’s asthma was well 4 managed: that the records described her condition as controlled, that her 5 pulmonary examinations were normal even during flareups, and that she has 6 not had to seek emergency treatment or hospital stays to treat her asthma. 7 These are also not clear and convincing reasons for discounting her testimony 8 about her nebulizer use. To be sure, evidence suggesting a claimant’s symptoms 9 are managed or improve with treatment may be a clear and convincing reason 10 for rejecting disabling symptoms. See Wellington v. Berryhill, 878 F.3d 867, 876 11 (9th Cir. 2017) (“evidence of medical treatment successfully relieving symptoms 12 can undermine a claim of disability”); Warre v. Comm’r of Soc. Sec. Admin., 439 13 F.3d 1001, 1006 (9th Cir. 2006) (“Impairments that can be controlled effectively 14 with medication are not disabling for the purpose of determining eligibility for 15 SSI benefits.”). It is not, however, a basis to reject testimony that the treatment 16 itself would be work preclusive. Here, Plaintiff did not testify that her asthma 17 was not fairly well controlled; instead, the import of her testimony was that she 18 had achieved some control over her condition precisely because she was able to 19 treat her condition with frequent nebulizer treatments, treatments of such 20 frequency and duration that they would impact her ability to work. As such, the 21 “controlled” nature of her asthma does not undermine Plaintiff’s testimony; it is 22 not inconsistent with that testimony. 23 Finally, the ALJ cited a single treatment note reporting that Plaintiff was 24 “relatively active” and able to do activities of daily living. (AR 28 (citing AR 25 26 6 The ALJ discussed the frequency of treatments. To the extent he meant to 27 include within that scope the duration of the treatments, the Court agrees with Plaintiff; there would be no reason for Plaintiff to report to her doctors how long 28 the prescribed treatments took to administer. 1 2399).) This, too, is also not particularly persuasive. It is true that where a 2 claimant engages in “daily activities that are incompatible with the severity of 3 symptoms alleged,” that can be a basis to discount subjective symptom 4 testimony. Trevizo v. Berryhill, 871 F.3d 664, 682 (9th Cir. 2017) (citing Ghanim 5 v. Colvin, 763 F.3d 1154, 1165 (9th Cir. 2014)). The note the ALJ cited was from 6 a 10-minute pain management telephone appointment in December 2022 and 7 solely stated that Plaintiff could “do ADL and be relatively active in current 8 regimen.” (AR 2398-99.) The note did not explain which activities Plaintiff could 9 do, what “relatively active” meant, or indicate whether Plaintiff’s activity level 10 was inconsistent with her need for nebulizer treatments. (AR 2399.) By contrast, 11 Plaintiff testified to activity, such as walking, that she fit in around her 12 nebulizer treatments. (AR 54-57.) ALJs must be mindful of the difference 13 between activities at home and the requirements of work—a place “where it 14 might be impossible to periodically rest or take medication.” Fair v. Bowen, 885 15 F.2d 597, 603 (9th Cir. 1989) (internal citations omitted), superseded on other 16 grounds by 20 C.F.R. § 404.1502(a).7 In short, the ALJ did not use permissible 17 bases to discount Plaintiff’s asthma-related testimony. 18 Moreover, any error with respect to the nebulizer testimony is not 19 harmless. The vocational expert testified that a person with Plaintiff’s RFC 20 could do Plaintiff’s past relevant work. (AR 63-65.) At the same time, he testified 21 that, if a hypothetical person were off task more than 15 percent of a workday 22 (as may be the case if she required four or more one-hour breathing treatments 23

24 7 “The critical differences between activities of daily living and activities in 25 a full-time job are that a person has more flexibility in scheduling the former than the latter, can get help from other persons. . . and is not held to a minimum 26 standard of performance, as she would be by an employer. The failure to recognize these differences is a recurrent, and deplorable, feature of opinions by 27 administrative law judges in social security disability cases.” Bjornson v. Astrue, 671 F.3d 640, 647 (7th Cir. 2012) (citations omitted) (cited with approval in 28 Garrison v. Colvin, 759 F.3d 995, 1016 (9th Cir. 2014). 1 a day), there would be no jobs that person could perform. (AR 66-67.) This 2 testimony was therefore crucial to the ALJ’s decision. 3 Defendant’s brief discusses the ALJ’s reasons for rejecting Plaintiff’s 4 testimony concerning other impairments to suggest that the ALJ showed his 5 work and did not arbitrarily discredit Plaintiff’s symptom allegations. (ECF 12 6 at 7-9.) To be affirmed, however, the ALJ must provide an adequate reason to 7 reject this testimony concerning her asthma treatments. Reddick, 157 F.3d at 8 722 (““General findings are insufficient; rather, the ALJ must identify what 9 testimony is not credible and what evidence undermines the claimant’s 10 complaints.”). He did not. Remand is therefore warranted. 11 IV. REMAND FOR FURTHER PROCEEDINGS 12 Remand (as opposed to an outright grant of benefits) is appropriate as the 13 circumstances of this case suggest that further administrative proceedings 14 could remedy the ALJ’s errors. See Dominguez v. Colvin, 808 F.3d 403, 407 (9th 15 Cir. 2015) (“Unless the district court concludes that further administrative 16 proceedings would serve no useful purpose, it may not remand with a direction 17 to provide benefits.”); Treichler v. Comm’r of Soc. Sec. Admin., 775 F.3d 1090, 18 1101, n.5 (9th Cir. 2014) (remand for further administrative proceedings is the 19 proper remedy “in all but the rarest cases”). As the ALJ failed to provide 20 persuasive reasons for rejecting Plaintiff’s asthma-related testimony, remand is 21 appropriate. Harman v. Apfel, 211 F.3d 1172, 1180-81 (9th Cir. 2000) (remand 22 for further proceedings rather than for the immediate payment of benefits is 23 appropriate where there are “sufficient unanswered questions in the record”). 24 V. ORDER 25 For all the foregoing reasons,8 IT IS ORDERED that: 26

27 8 The Court has not reached any other issue raised by Plaintiff except to determine that reversal with a directive for the immediate payment of benefits 28 (cont’d . . .) 1 (1) the decision of the Commissioner is REVERSED, and this matter is 2 REMANDED pursuant to sentence four of 42 U.S.C. § 405(g) for 3 further administrative proceedings consistent with this Memorandum 4 Opinion and Order; and 5 (2) Judgment be entered in favor of Plaintiff.

7 || DATED: October 21, 2025 BRIANNA FULLER MIRCHEFF UNITED STATES MAGISTRATE JUDGE 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 || would not be appropriate at this time. See Hiler v. Astrue, 687 F.3d 1208, 1212 95 || (9th Cir. 2012) (“Because we remand the case to the ALJ for the reasons stated, we decline to reach [plaintiff's] alternative ground for remand.”); see also 26 || Augustine ex rel. Ramirez v. Astrue, 536 F. Supp. 2d 1147, 1158 n.7 (C.D. Cal. 2008) (“[The] Court need not address the other claims plaintiff raises, none of 27 || which would provide plaintiff with any further relief than granted, and all of 28 which can be addressed on remand.”). 12